Probiotics Safety Aspect of Functional Foods

MakaleAçık Erişim
  • SDG 3 · Sağlık ve Kaliteli Yaşam

Özet

In recent years, interest in probiotics has increased as functional foods improve quality of life and consumers become more health-conscious. The European Food Safety Authority (EFSA) has determined that all common probiotics are safe for the general population. However, this definition does not guide the outcomes of using probiotics in people with diseases that favor them, as there are no strict regulations governing applicable trademark law and the manufacture of probiotics. For this reason, Probiotics are recognized to be beneficial for the majority of patients during treatment; however, patients with weakened immune systems may be at risk for bacteremia, endocarditis, and peritonitis. There are no necessary standards regarding safety and use protocols for probiotics. More information is needed on their use before recommending probiotics to treat or prevent disease in privileged groups. These products may be considered a public health concern by reviewing information on the use of probiotics to predict the likelihood of side effects in vulnerable groups (young children, the elderly, and pregnant women).

Anahtar Kelimeler

RDL Kalıcı Bağlantı (PID)
https://rdlopen.rawdatalibrary.net/r/gumushane/12620Resmi atıflarda kullanılan kalıcı adres
Tam Kayıt
AlanDeğerDil
dc.contributor.authorOba, Sirin
dc.contributor.authorYildirim, Tugce
dc.contributor.authorKarataş, Şeyda Merve
dc.date.accessioned2026-10-22T10:20:20.452478881Z
dc.date.available2026-10-22T10:20:20.452478881Z
dc.date.issued2024
dc.description.abstractIn recent years, interest in probiotics has increased as functional foods improve quality of life and consumers become more health-conscious. The European Food Safety Authority (EFSA) has determined that all common probiotics are safe for the general population. However, this definition does not guide the outcomes of using probiotics in people with diseases that favor them, as there are no strict regulations governing applicable trademark law and the manufacture of probiotics. For this reason, Probiotics are recognized to be beneficial for the majority of patients during treatment; however, patients with weakened immune systems may be at risk for bacteremia, endocarditis, and peritonitis. There are no necessary standards regarding safety and use protocols for probiotics. More information is needed on their use before recommending probiotics to treat or prevent disease in privileged groups. These products may be considered a public health concern by reviewing information on the use of probiotics to predict the likelihood of side effects in vulnerable groups (young children, the elderly, and pregnant women).
dc.description.sponsorshipAmasya Üniversitesi, (000000000)
dc.identifier.doi10.1080/15428052.2022.2135156
dc.identifier.eissn1542-8044
dc.identifier.endpage1356
dc.identifier.issn1542-8052
dc.identifier.issue6
dc.identifier.scopus2-s2.0-85140104822
dc.identifier.startpage1327
dc.identifier.urihttps://rdlopen.rawdatalibrary.net/r/gumushane/12620
dc.identifier.volume22
dc.identifier.wosWOS:000870165900001
dc.language.isoen
dc.publisherTaylor and Francis Ltd.
dc.relation.ispartofJournal of Culinary Science and Technology
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectfunctional food
dc.subjecthealth
dc.subjectProbiotic
dc.subjectsafety
dc.subject.classificationFood Science & Technology
dc.subject.otherBacteriology
dc.subject.otherFood microbiology
dc.subject.otherFood safety
dc.subject.otherHealth risks
dc.subject.otherInformation use
dc.subject.otherLaws and legislation
dc.subject.otherPatient treatment
dc.subject.otherEuropean food safety authorities
dc.subject.otherGeneral population
dc.subject.otherHealth concerns
dc.subject.otherHealth conscious
dc.subject.otherProbiotics
dc.subject.otherQuality of life
dc.subject.otherSafety aspects
dc.subject.otherSide effect
dc.subject.otherVulnerable groups
dc.subject.otherYoung children
dc.titleProbiotics Safety Aspect of Functional Foods
dc.typeArticle
dspace.entity.typePublication
rdl.citation.openalex6
rdl.citation.scopus7
rdl.citation.wos6
rdl.oa.statusgreen
rdl.oa.statuspreprint
rdl.oa.urlhttps://hdl.handle.net/20.500.12440/5708
rdl.publication.statusearlyAccess
rdl.sdgSDG03
rdl.source.indexSCOPUS
rdl.source.indexWOS
rdl.wos.indexEmerging Sources Citation Index (ESCI)